Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
95.57
+1.89 (2.02%)
Mar 14, 2025, 10:55 AM EDT - Market open
Encompass Health Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Encompass Health stock have an average target of 107.38, with a low estimate of 95 and a high estimate of 120. The average target predicts an increase of 12.36% from the current stock price of 95.57.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 11, 2025.
Analyst Ratings
The average analyst rating for Encompass Health stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $110 | Buy | Reiterates | $110 | +15.10% | Feb 11, 2025 |
| Keybanc | Keybanc | Buy Maintains $117 → $120 | Buy | Maintains | $117 → $120 | +25.56% | Feb 10, 2025 |
| Barclays | Barclays | Buy Maintains $116 → $118 | Buy | Maintains | $116 → $118 | +23.47% | Feb 7, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $105 → $110 | Buy | Maintains | $105 → $110 | +15.10% | Oct 30, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $108 → $116 | Strong Buy | Reiterates | $108 → $116 | +21.38% | Oct 30, 2024 |
Financial Forecast
Revenue This Year
5.92B
from 5.37B
Increased by 10.10%
Revenue Next Year
6.43B
from 5.92B
Increased by 8.67%
EPS This Year
4.84
from 4.46
Increased by 8.60%
EPS Next Year
5.37
from 4.84
Increased by 10.97%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.2B | 6.8B | 7.4B |
| Avg | 5.9B | 6.4B | 7.0B |
| Low | 5.7B | 6.2B | 6.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 15.0% | 14.5% | 14.8% |
| Avg | 10.1% | 8.7% | 8.2% |
| Low | 6.2% | 4.1% | 3.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 5.16 | 6.01 | 6.73 | |
| Avg | 4.84 | 5.37 | 6.01 | |
| Low | 4.33 | 4.79 | 5.13 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 15.6% | 24.0% | 25.2% | |
| Avg | 8.6% | 11.0% | 11.8% | |
| Low | -2.9% | -1.0% | -4.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.